Last reviewed · How we verify
Weight reduction
At a glance
| Generic name | Weight reduction |
|---|---|
| Sponsor | Assaf-Harofeh Medical Center |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Screening and Multiple Intervention on Lung Epidemics (PHASE2)
- A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer (PHASE2)
- "Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition" (NA)
- Reducing Symptom Burden Through Physical Exercise in Melanoma Patients (NA)
- MODERN-Dental: Pediatric Obesity, Cardiometabolic Risks, And Periodontal Disease (NA)
- A Study of a Weight Loss Intervention in People With Endometrial Cancer (EARLY_PHASE1)
- A Natural History of Genetic and Environmental Predictors of Pubertal Timing Among Youth With Obesity
- Using Technology to Investigate Lapses in a Weight Loss Program Among Individuals With Overweight and Obesity (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Weight reduction CI brief — competitive landscape report
- Weight reduction updates RSS · CI watch RSS
- Assaf-Harofeh Medical Center portfolio CI